Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Has results
×
ublituximab
×
Clear all
Filters
3
NCT03801525
2024-04-19
ULTRA-V
TG Therapeutics, Inc.
Phase 2/3
Terminated
277 enrolled
19 charts